References
- Ahmad FB, Rossen LM, Sutton P. Provisional drug overdose death counts. Hyattsville, MD: National Center for Health Statistics; 2021.
- Hasegawa K, Espinola JA, Brown DF, et al. Trends in U.S. emergency department visits for opioid overdose, 1993–2010. Pain Med. 2014;15(10):1765–1770.
- Langabeer JR, Stotts AL, Bobrow BJ, et al. Prevalence and charges of opioid-related visits to U.S. emergency departments. Drug Alcohol Depend. 2021;221:108568.
- Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project (HCUP) Fast Stats – Opioid-Related Hospital Use. 2021. Available at: www.hcup-us.ahrq.gov/faststats/opioid/opioiduse.jsp?radio3=on&location1=US&characteristic1=01&setting1=ED&location2=&characteristic2=01&setting2=IP&expansionInfoState=hide&dataTablesState=hide&definitionsState=hide&exportState=hide.
- Martin A, Mitchell A, Wakeman S, et al. Emergency department treatment of opioid addiction: an opportunity to Lead. Acad Emerg Med. 2018;25(5):601–604.
- Strayer RJ, Hawk K, Hayes BD, et al. Management of opioid use disorder in the emergency department: a white paper prepared for the American Academy of Emergency Medicine. J Emerg Med. 2020;58(3):522–546.
- Hawk K, Hoppe J, Ketcham E, et al. Consensus recommendations on the treatment of opioid use disorder in the emergency department. Ann Emerg Med. 2021;S0196-0644(21):00306–00301.
- D'Onofrio G, O'Connor PG, Pantalon MV, et al. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313(16):1636–1644.
- D'Onofrio G, Chawarski MC, O'Connor PG, et al. Emergency Department-Initiated buprenorphine for opioid dependence with continuation in primary care: Outcomes during and after intervention. J Gen Intern Med. 2017;32(6):660–666.
- Dunkley CA, Carpenter JE, Murray BP, et al. Retrospective review of a novel approach to buprenorphine induction in the emergency department. J Emerg Med. 2019;57(2):181–186.
- Kaucher KA, Caruso EH, Sungar G, et al. Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program. Am J Emerg Med. 2020;38(2):300–304.
- Busch SH, Fiellin DA, Chawarski MC, et al. Cost-effectiveness of emergency department-initiated treatment for opioid dependence. Addiction. 2017;112(11):2002–2010.
- Martin A, Butler K, Chavez T, et al. Beyond buprenorphine: models of follow-up care for opioid use disorder in the Emergeny Department. West J Emerg Med. 2020;21(6):257–263.
- Cunningham CO, Giovanniello A, Li X, et al. A comparison of buprenorphine induction strategies: patient-centered home-based inductions versus standard-of-care office-based inductions. J Subst Abuse Treat. 2011;40(4):349–356.
- Moe J, Badke K, Pratt M, et al. Microdosing and standard-dosing take-home buprenorphine from the emergency department: a feasibility study. J Am Coll Emerg Physicians Open. 2020;1(6):1712–1722.
- Martin A, Baugh J, Chavez T, et al. Clinician experience of nudges to increase ED OUD treatment. Am J Emerg Med. 2020;38(10):2241–2242.
- Bogan C, Jennings L, Haynes L, et al. Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural Southern state. J Subst Abuse Treat. 2020;112S:73–78.